These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15453867)

  • 1. First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome.
    De Santis M; Carducci B; De Santis L; Lucchese A; Straface G
    Acta Ophthalmol Scand; 2004 Oct; 82(5):623-4. PubMed ID: 15453867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accidental pregnancy exposure to verteporfin: obstetrical and neonatal outcomes: a case report.
    Rodrigues M; Meira D; Batista S; Carrilho MM
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):236-7. PubMed ID: 19432621
    [No Abstract]   [Full Text] [Related]  

  • 3. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy for choroidal neovascular membrane secondary to optic nerve drusen.
    Chaudhry NA; Lavaque AJ; Shah A; Liggett PE
    Ophthalmic Surg Lasers Imaging; 2005; 36(1):70-2. PubMed ID: 15688974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent disappearance of choroidal neovascularization after initial photodynamic therapy with verteporfin.
    Sawa M; Ohji M; Gomi F; Kusaka S; Tano Y; Bressler NM
    Arch Ophthalmol; 2002 Nov; 120(11):1588-90. PubMed ID: 12427082
    [No Abstract]   [Full Text] [Related]  

  • 7. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Bressler NM;
    Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy.
    Ergun E; Tittl M; Stur M
    Arch Ophthalmol; 2004 Jan; 122(1):37-41. PubMed ID: 14718292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
    Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verteporfin therapy for choroidal neovascularization: from concept to proof of efficacy.
    Sickenberg M
    Semin Ophthalmol; 2001 Dec; 16(4):177-80. PubMed ID: 15513439
    [No Abstract]   [Full Text] [Related]  

  • 11. Photodynamic therapy with verteporfin for choroidal neovascularization complicating angioid streaks.
    Karadimas P; Bouzas EA
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):78-80. PubMed ID: 14750772
    [No Abstract]   [Full Text] [Related]  

  • 12. Verteporfin photodynamic therapy involving the optic nerve for peripapillary choroidal neovascularization.
    Bernstein PS; Horn RS
    Retina; 2008 Jan; 28(1):81-4. PubMed ID: 18185142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
    Schmidt-Erfurth UM; Michels S
    Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verteporfin in Photodynamic Therapy: report no. 5.
    Bandello F; Blinder K; Bressler NM; Brown AL; Miller JW; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Slakter JS; Soubrane G; Strong HA; Stur M;
    Ophthalmology; 2004 Nov; 111(11):2144. PubMed ID: 15522385
    [No Abstract]   [Full Text] [Related]  

  • 15. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
    Browning AC; Chung AK; Ghanchi F; Harding SP; Musadiq M; Talks SJ; Yang YC; Amoaku WM;
    Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia.
    Gibson J
    Eye (Lond); 2005 Aug; 19(8):829-30. PubMed ID: 16086038
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
    Hariprasad SM; Shah GK
    Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verteporfin photodynamic therapy in the UK: implications of the NICE appraisal.
    Harding S
    Eye (Lond); 2003 Mar; 17(2):119-22. PubMed ID: 12640394
    [No Abstract]   [Full Text] [Related]  

  • 20. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.
    Bressler NM; Bressler SB
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):624-8. PubMed ID: 10711673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.